Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.011 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Aug-2020Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer A Phase 1 and Randomized Phase 2 TrialCortés, Javier; Dieras, Veronique; Lorenzen, Sylvie; Montemurro, Filippo; Riera-Knorrenschild, Jorge; Thuss-Patience, Peter; Allegrini, Giacomo; Laurentiis, Michele De; Lohrisch, Caroline; Oravcova, Eva; Pérez García, José Manuel; Ricci, Francesco; Sakaeva, Dina; Serpanchy, Rosanne; Sufliarsky, Jozef; Vidal Losada, Maria Jesús; Irahara, Natsumi; Wohlfarth, Christine; Aout, Mounir; Gelmon, Karen
13-May-2020Frequency and spectrum of PIK3CA somatic mutations in breast cancerMartínez Sáez, Olga; Chic, Núria; Pascual, Tomás; Adamo, Barbara; Vidal Losada, Maria Jesús; Gonzalez-Farre, Xavier; Sanfeliu, Esther; Schettini, Francesco; Conte, Benedetta; Brasó Maristany, Fara; Rodriguez, Adela; Martínez, Debora; Galván, Patricia; Rodríguez, Ana Belén; Martínez, Antonio; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix
1-Dec-2020Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib TrialLópez Miranda, Elena; Pérez García, José Manuel; Cosimo, Serena Di; Brain, Etienne; Ravnik, Maja; Escrivá de Romaní, Santiago; Vidal Losada, Maria Jesús; Gligorov, Joseph; Borstnar, Simona; Calabuig, Laura; Sampayo-Cordero, Miguel; Malfettone, Andrea; Llombart Cussac, Antonio; Suter, Thomas M.; Cortés, Javier
23-Apr-2021SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast CancerPascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix
4-Jan-2021Clinical, pathological and PAM50 gene expression features of HER2-low breast cancerPrat Aparicio, Aleix; Schettini, Francesco; Chic, Núria; Brasó Maristany, Fara; Paré, Laia; Pascual, Tomás; Conte, Benedetta; Martínez Sáez, Olga; Adamo, Barbara; Vidal Losada, Maria Jesús; Fernández Martínez, Aranzazu; González Farré, Blanca; Sanfeliu, Esther; Cejalvo Andújar, Juan Miguel; Perrone, Giuseppe; Sabarese, Giovanna; Zalfa, Francesca; Villagrasa, Patricia; Gavilá, Joaquín; Barrios, Carlos H.; Lluch, Ana; Martín, Miguel; Placido, Sabino De; Barnadas, Esther; Locci, Mariavittoria; Peg, Vicente; Fasan, Roberta
14-Jul-2020ERBB2mRNA expression and response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-positive breast cancerGriguolo, Gaia; Brasó Maristany, Fara; González Farré, Blanca; Pascual, Tomás; Chic, Núria; Saurí, Tamara; Kates, Ronald; Gluz, Oleg; Martínez, Débora; Paré, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz Mateu, Montserrat; Galván, Patricia; Barberá, Laura; Cuatrecasas Freixas, Miriam; Christgen, Mathias; Kreipe, Hans; Monge Escartín, Inés; Villagrasa, Patricia; Soy Muner, Dolors; Giarratano, Tommaso; Dieci, Maria Vittoria; Conte, Pierfranco; Harbeck, Nadia; Guarneri, Valentina; Prat Aparicio, Aleix